Existence Genetics

By Justin Petrone
Existence Genetics, a Los Angeles-based genetic testing company, recently introduced a new service that relies on microarray technology to screen customers for their risk for around 1,000 rare diseases.

New Releases

Premium

Existence Genetics has launched a genetic testing service that analyzes customers' risk for more than 1,000 diseases, traits, and medication reactions in a single run.

The predictive medicine company will use the Oragene DNA saliva-based collection kit.

The company's current technology is based on DNA microarray chips, but its founder and CEO said that once whole-genome sequencing becomes a routine medical procedure, its business model will change and allow the company to truly take off.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.